X
[{"orgOrder":0,"company":"Locate Bio","sponsor":"Mercia Asset Management","pharmaFlowCategory":"D","amount":"$13.7 million","upfrontCash":"Undisclosed","newsHeadline":"Locate Bio Closes \u00a310 million Funding Round","therapeuticArea":"Neurology","highestDevelopmentStatus":"Undisclosed","country":"UNITED KINGDOM","productType":"Large molecule","productStatus":"New Molecular Entity","date":"September 2021","url1":"","url2":"","graph1":"Neurology","graph2":"Undisclosed"},{"orgOrder":0,"company":"Locate Bio","sponsor":"Mercia Ventures","pharmaFlowCategory":"D","amount":"$9.8 million","upfrontCash":"Undisclosed","newsHeadline":"Locate Bio Raises \u00a39.2 Million to Progress LDGraft Clinical Study for Anterior Lumbar Interbody Fusion","therapeuticArea":"Orthopedics\/Orthopedic Surgery","highestDevelopmentStatus":"Preclinical","country":"UNITED KINGDOM","productType":"Large molecule","productStatus":"New Molecular Entity","date":"April 2024","url1":"","url2":"","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Preclinical"}]
Find Clinical Drug Pipeline Developments & Deals by Locate Bio
Filters
Companies By Therapeutic Area
Details:
The proceeds will be used to advance the clinical development of Locate Bio's lead product, LDGraft (rhBMP-2), which is currently undergoing evaluation in early-stage clinical trials for treating patients with degenerative disc disease.
Lead Product(s):
rhBMP-2
Therapeutic Area: Orthopedics/Orthopedic Surgery
Product Name: LDGraft
Highest Development Status: Preclinical
Product Type: Large molecule
Partner/Sponsor/Collaborator:
Mercia Ventures
Deal Size: $9.8 million
Upfront Cash: Undisclosed
Deal Type: Funding
April 29, 2024
Details:
The funding will be used to advance Locate Bio’s proprietary pipeline, including its lead product called LDGraft, a low dose, controlled release rhBMP-2 for the treatment of degenerative disc disease.
Lead Product(s):
rhBMP-2
Therapeutic Area: Neurology
Product Name: LDGraft
Highest Development Status: Undisclosed
Product Type: Large molecule
Partner/Sponsor/Collaborator:
Mercia Asset Management
Deal Size: $13.7 million
Upfront Cash: Undisclosed
Deal Type: Funding
September 03, 2021